CN
226-214-6
Applied Filters:
Keyword:'226-214-6'
Showing 1-28 of 28 results for "226-214-6" within Technical Documents
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
Expected Range Units Cytokine QC Level Expected Range Units
EGF Control 1 103 - 214 pg/mL IL-12 (p70) Control 1 109 - 226 pg/mL
Control 2 536 - 1113 pg/mL
XP725 Antibody Number-Lot Number 071M4826
225 226 227 228 249 250 251 252 273 274 275 276
3.4 205 206 207 208 229 230 231 232 253 254 255 256 277 278 279 280
3.5 209 210 211 212 233 234 235 236 257 258 259 260
Product Information Sheet - F4274
.H., and Feltkamp, T.E.W., Immunology, 18,
865-873 and 875-881 (1970).
6. Goding, J.W., J. Immunol. Methods, 13, 215-226
(1976).
7. NCCLS Approved Standard:ASM-1, 2nd Ed. (June
1975). Standard
Product Information Sheet - F4002
.H., and Feltkamp, T.E.W., Immunology, 18,
865-873 and 875-881 (1970).
6. Goding, J.W., J. Immunol. Methods, 13, 215-226
(1976).
7. NCCLS Approved Standard:ASM-1, 2nd Ed. (June
1975). Standard
Product Information Sheet - F7250
.H., and Feltkamp, T.E.W., Immunology, 18,
865-873 and 875-881 (1970).
6. Goding, J.W., J. Immunol. Methods, 13, 215-226
(1976).
7. NCCLS Approved Standard:ASM-1, 2nd Ed. (June
1975). Standard
Product Information Sheet - F3651
.H., and Feltkamp, T.E.W., Immunology, 18,
865-873 and 875-881 (1970).
6. Goding, J.W., J. Immunol. Methods, 13, 215-226
(1976).
7. NCCLS Approved Standard:ASM-1, 2nd Ed. (June
1975). Standard
Product Information Sheet - CYTOCOX1
.,
182, 214-215 (1990).
4. Hovius, R., et al., Biochim. Biophys. Acta, 1021,
217-226 (1990).
5. Rasmussen, U.F., and Rasmussen, H.N., Mol. Cell.
Biochem., 208, 37-44 (2000).
6. Musatov, A
Product Information Sheet - PP0500
., Biochem. Biophy. Res.
Commun., 280, 1367-1371 (2001).
28. Gupta, M.N. et al., Proteins, 39, 226-234 (2000).
29. Gupta, M.N., Eur. J. Biochem., 203, 25-32 (1992).
30. Minotti, A.M. et al., Anal. Biochem
Data Sheet - 77237
et al., Life Sci., 54, 1403-1409 (1994).
Kurosawa, M. et al., Int. Arch. Allergy Immunol., 97, 226-228 (1992).
Thymocytes
Hoshino. J. et al., Biochem. International, 27, 105-116 (1992).
Percoll - Product Information Sheet
-670 (1977).
Page 6 of 7
CHO Membranes
Cezanne, L.
Product Information Sheet - P4937
N. et al., Life Sci., 54, 1403-1409 (1994).
Kurosawa, M. et al., Int. Arch. Allergy Immunol., 97,
226-228 (1992).
Thymocytes
Hoshino. J. et al., Biochem. International, 27, 105-116
(1992).
Fearnhead
Product Information Sheet - E0414
N. et al., Life Sci., 54, 1403-1409 (1994).
Kurosawa, M. et al., Int. Arch. Allergy Immunol., 97,
226-228 (1992).
Thymocytes
Hoshino. J. et al., Biochem. International, 27, 105-116
(1992).
Fearnhead
Product Information Sheet - P7828
N. et al., Life Sci., 54, 1403-1409 (1994).
Kurosawa, M. et al., Int. Arch. Allergy Immunol., 97,
226-228 (1992).
Thymocytes
Hoshino. J. et al., Biochem. International, 27, 105-116
(1992).
Fearnhead
Product Information Sheet - P1644
N. et al., Life Sci., 54, 1403-1409 (1994).
Kurosawa, M. et al., Int. Arch. Allergy Immunol., 97,
226-228 (1992).
Thymocytes
Hoshino. J. et al., Biochem. International, 27, 105-116
(1992).
Fearnhead
User Guide Equinox SOP Software 2.1 for Windows XP
cambios.
6. Hacer clic en ”OK” para confirmar el mensaje, y después reiniciar el programa.
Figura 36: Configuración
Figura 37: Seleccionar la ruta de las copias de seguridad
226 — Otras funciones
List of Antibodies
www.sigmaaldrich.com/ProductLookup.html?ProdNo=C5987&Brand=SIGMA�
186 COX II C9354 M y n/d n/d
226 Dnase II D1689 P y n/d n/d
149 Cdc14A C2238 M y n/d n/d
150 Cdc25c
Cytoskeletal Signaling Antibodies, Reagents and Kits
Monoclonal Antibody
Anti-phospho-MEK1 (Ser218/222)/ H M R WB Pur Rb IgG 100 µL 05-747
MEK2 (Ser222/226)
Anti-MEK1, NT C12T Ca H M IP WB Pur Rb IgG 100 µL 05-925
Mk R Rb
Anti-MEK1
XP725 Antibody List Lot 129K4831
237 Dystrophin D8168 1756 DMD M NP_000100.2 y y y
238 Dystrophin D8043 1756 DMD M NP_000100.2 y y y
226 Dnase II D1689 1777 DNASE2 P NP_001366.1 y n/d n/d
227 DNMT1 D4567 1786 DNMT1 P NP_001124295.1 y y
XP725 Antibody List Lot 129K4830
237 Dystrophin D8168 1756 DMD M NP_000100.2 y y y
238 Dystrophin D8043 1756 DMD M NP_000100.2 y y y
226 Dnase II D1689 1777 DNASE2 P NP_001366.1 y n/d n/d
227 DNMT1 D4567 1786 DNMT1 P NP_001124295.1 y y
XP725 Antibody List Lot 089K4791
237 Dystrophin D8168 1756 DMD M NP_000100.2 y y y
238 Dystrophin D8043 1756 DMD M NP_000100.2 y y y
226 Dnase II D1689 1777 DNASE2 P NP_001366.1 y n/d n/d
227 DNMT1 D4567 1786 DNMT1 P NP_001124295.1 y y
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
MEK1 and MEK2 are activated by phosphorylation of two serine residues (Ser218/222 in MEK1 and
Ser222/226 in MEK2), which are substrates for the Raf family of kinases. Mutation of the phosphorylation sites
Millipore's 2008 Sustainability Report
methodology.
*1 m3 = 35.3 ft3 = 264.2 gallons
836 881
2006 2007 2008
615
200
21
636
226
19 803
562
223
18
water use by
Halal Certificate
HYDROXY-2-CYCLOPENTEN-1-ONE SOLUTION
50 WT. % IN PROPYLENE GLYCOL
W315214 B60245 HC-23SIKR58
226. 3-ETHYL-2-HYDROXY-2-CYCLOPENTEN-1-ONE, 97% W315206 B63717 HC-23SIDB87
227. 3-ETHYLPYRIDINE 98%
Halal Certificate
HYDROXY-2-CYCLOPENTEN-1-ONE SOLUTION
50 WT. % IN PROPYLENE GLYCOL
W315214 B60245 HC-22SID779
226. 3-ETHYL-2-HYDROXY-2-CYCLOPENTEN-1-ONE, 97% W315206 B63717 HC-22SIP409
227. 3-ETHYLPYRIDINE 98%
XP725 Antibody List 013M4793
Dstn,DSTN NP_062745.1,XP_215862.3,NP_006861.1 P y y y
225 Dnase I D0188 282217 DNASE1 P n/d n/d n/d
226 Dnase II D1689 1777 DNASE2 NP_001366.1 P y n/d n/d
227 DNMT1 D4567 13433, 1786 Dnmt1,DNMT1 NP_034196.3
XP725 Antibody List
Dstn,DSTN NP_062745.1,XP_215862.3,NP_006861.1 P y y y
225 Dnase I D0188 282217 DNASE1 P n/d n/d n/d
226 Dnase II D1689 1777 DNASE2 NP_001366.1 P y n/d n/d
227 DNMT1 D4567 13433, 1786 Dnmt1,DNMT1 NP_034196.3
3D BIOPRINTING: Printing a Brighter Future
Nature 2012, 489, 133.
(225) Fuchs, S.; Shariati, K.; Ma, M. Adv. Healthc.Mater. 2020, 9, 1901396.
(226) Oveissi, F.; Fletcher, D. F.; Dehghani, F.; Naficy, S. Mater. Des. 2021,
109609.
(227) Dubbin
3D BIOPRINTING: Printing a Brighter Future
Nature 2012, 489, 133.
(225) Fuchs, S.; Shariati, K.; Ma, M. Adv. Healthc.Mater. 2020, 9, 1901396.
(226) Oveissi, F.; Fletcher, D. F.; Dehghani, F.; Naficy, S. Mater. Des. 2021,
109609.
(227) Dubbin